Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,067 public trials 1,185 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Not yet recruiting

Neoadjuvant PDT in the Treatment of Cholangiocarcinoma

NCT04824742

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Yi Lv Xi'an, Shaanxi, China

View Trial Details

Not yet recruiting

Hepatocarcinoma Recurrence on the Liver Study - Part2

NCT04053231

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Chirurgia Rubino - Policlinico di Bari Bari, Italy

Ospedale Maggiore- AUSL Bologna, Italy

Chirurgia Generale Bolzano Bolzano, Italy

Fondazione Poliambulanza - Istituto Ospedaliero Brescia, Italy

View all 19 locations

View Trial Details

Not yet recruiting

Laparoscopic Surgery VS RFA for Recurrent HCC

NCT02785380

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

NCT02779465

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +23 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

NCT07620574

Conditions: Adenocarcinoma, Cancer, Carcinoma, +39 more
Locations: New York Cancer and Blood Specialists Bay Shore, New York, United States

Greater Dayton Cancer Center Kettering, Ohio, United States

View Trial Details

Enrolling by invitation

Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma

NCT07713901

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations: IQVIA Parsippany, New Jersey, United States

View Trial Details

Enrolling by invitation

Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma

NCT07703735

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Enrolling by invitation

OE MRI to Predict Treatment Response After TACE in HCC Patients

NCT07617038

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: CRCHUM Montreal, Quebec, Canada

View Trial Details

Enrolling by invitation

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

NCT06885424

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
Locations: Banner Health Gilbert, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

NYU Langone Medical Center New York, United States

View Trial Details

Enrolling by invitation

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

NCT07298577

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +29 more
Locations: Faculty of Medicine Siriraj Hospital Bangkok Noi, Bangkok, Thailand

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions